#NEWS: Today, the @fda.gov approved our orally administered therapy for patients with HER2 (ERBB2)-mutant advanced non-small cell lung cancer (NSCLC) as an initial treatment. This marks the first approved targeted therapy for this use.
Learn more: go.boehringer.com/VHCH-
#LifeForward
#NEWS: New Phase II trial results in primary focal segmental glomerulosclerosis (FSGS) published in The Lancet.
Primary FSGS is a rare, progressive kidney disease, which can end in kidney failure.
Read more 👉 go.boehringer.com/VecpO
#LifeForward
#NEWS: The @fda.gov has approved our new treatment for progressive pulmonary fibrosis (PPF) in adults. The approval provides hope to people living with this life-threatening condition.
Learn more here: go.boehringer.com/SYRTX
#LifeForward #PulmonaryFibrosis
#NEWS: China’s National Medical Products Administration (NMPA) has approved our new treatment for progressive #PulmonaryFibrosis (PPF). 🧪
In a field where milestones are scarce, today signals meaningful momentum for the PPF community.
Learn more: go.boehringer.com/ao0kp
#LifeForward
#NEWS: Our investigational targeted therapy has been awarded a Commissioner’s National Priority Voucher from the U.S. FDA.
Find out more here go.boehringer.com/Fyr8N
#LifeForward #Oncology
#LifeForward #BoilingIslesReconstructionPeriod #Why
#Therapy #Anxiety #Alador #Divorce #Dad-Dating Whacky
The immune system has the remarkable ability to identify and eliminate cancer cells.
Our oncology research includes the investigation of T-cell engagers, focusing on leveraging immune mechanisms in cancer therapy.
Learn more 🧪: go.boehringer.com/Ki82v
#LifeForward #Oncology
#NEWS: Our latest oncology research in HER2 (ERBB2)-mutant advanced non-small cell lung cancer (NSCLC) has been presented at #ESMO25.
These advancements have the potential to fulfill patients’ unmet needs.
🧪 Find out more: go.boehringer.com/FU9K9
#LifeForward #Oncology
Living with cancer, the small, positive moments often have the biggest impact.
We're here to celebrate these 'Big Little Things': small victories, time with loved ones, and everyday joys.
🧪 Discover how these moments make a difference: go.boehringer.com/YomJY
#LifeForward #Oncology
#NEWS: Ten of our oncology abstracts will be presented at #ESMO25, sharing our ongoing research efforts in hard-to-treat cancers.
🧪 Learn more: go.boehringer.com/GCZ1
#LifeForward #Oncology
#NEWS: The U.S. Food and Drug Administration (FDA) has approved the first new treatment for idiopathic pulmonary fibrosis (#IPF) in over a decade. 🧪
Learn more here: go.boehringer.com/rtx-w
#LifeForward
#NEWS: New pooled phase III data in idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF) presented at the European Respiratory Society (ERS) Congress 2025: go.boehringer.com/rdYYD 🧪
#ERS2025 #LifeForward
#NEWS for media: Our targeted cancer therapy has received approval in China for use in previously treated people with HER2 (ERBB2)-mutant advanced non-small cell lung cancer (NSCLC). 🧪
Learn more here: go.boehringer.com/YrIQ
#LifeForward #Oncology
At 37, Samantha was diagnosed with non-small cell #lungcancer (NSCLC).
With support from her husband Justin and care team, she learned about #biomarker testing 🧪 to understand her cancer’s unique profile.
#LifeForward #Oncology #Medsky
#NEWS for media: Our targeted cancer therapy has been approved in the U.S. for people with HER2 (ERBB2)-mutant advanced non-small cell lung cancer by the U.S. @fda.gov.
Learn more here 👉: www.boehringer-ingelheim.com/human-health...
#LifeForward #Oncology
#NEWS: We’re kicking off a new chapter in digital health through our collaboration with Eko Health to improve heart murmur detection in dogs. We will bring an AI-powered tool to veterinarians to give dogs and pet owners more years of life to love. 🐕 #LifeForward
Learn more: go.boehringer.com/4olwa
#NEWS: Pivotal FIBRONEER™-IPF and FIBRONEER™-ILD phase III full data in IPF and PPF presented at #ATS2025 and published in @nejm.org. IPF and PPF are serious conditions that can cause irreversible lung damage and continued decline in lung function. 🧪 👉 go.boehringer.com/1fG0l
#LifeForward
#NEWS: New survey shows over 90% of animal owners trust and appreciate veterinary teams but underestimate the profession’s demands. Learn more: 👉 go.boehringer.com/o9qo
Survey conducted with Kynetec.
#WorldVeterinaryDay #LifeForward
Our mission is to redefine mental health care. We invest in research and forge unique partnerships to help transform lives. Though the journey is complex, we’re committed to ‘failing forward’— using every setback as a stepping stone toward progress. Learn more: bit.ly/42kZqSw #LifeForward
In our 2024 #AnnualReport Magazine titled 'Think Beyond' we reflect on our achievements and showcase some amazing stories and voices of our colleagues and other experts. Take a look at where we find our purpose, what drives us and where we strive to make a difference. ➡️ bit.ly/4cetX9m
#LifeForward
🧪#NEWS: We are looking forward to working with
@saliprobiotech.bsky.social's team of scientists, to develop new medicines addressing challenging drug targets to transform patients' lives. #science #LifeForward
🧪 Meet our colleague Dr. Zeena Williams whose team ensures the quality of new compounds made for patients in clinical trials. It was her teacher who instilled her passion for chemistry.
Learn how Zeena supports future women in #science: go.boehringer.com/kq2IX
#LifeForward #WomenInSTEM #chemsky
Every minute, 30 people worldwide suffer a #stroke. Our colleague Horst was one of them. His story highlights how swift action can significantly improve the chances of long-term recovery: go.boehringer.com/UHT3
#LifeForward
Pregnant and breastfeeding individuals are one of the traditionally underrepresented groups in #ClinicalTrials. Xu Ling, our Head of Quality Medicine in China, is committed to solve this problem. Learn what breaking new ground as a #WomenInScience means to her: go.boehringer.com/100uL
#LifeForward
Looking for #WomenInSTEM in history books? Our site in Ochsenhausen, Germany, has been founded by two women in 1971. Hear more from our colleague Dr. Ingrid Rapp who joined the lab in the 90s and was part of the transformation into a biotech company: go.boehringer.com/C_8j5
#LifeForward
#WomenInSTEM have been breaking new ground - yesterday, today, and tomorrow. On the 10th International Day of Women and Girls in Science, we share the stories of our colleagues Ingrid, Ling, and Zeena. See what working in science means for them: go.boehringer.com/wEaFd
#LifeForward
